Form 4: ALX Oncology CFO Peter Garcia Reports Tax-Related Stock Disposal
SEC Form 4 Filing
Peter Garcia, CFO of ALX Oncology Holdings Inc., reports the disposal of 761 common stock shares to cover tax obligations related to vesting restricted stock units.
Summary
- On August 14, 2024, Peter Garcia, the Chief Financial Officer of ALX Oncology Holdings Inc., disposed of 761 shares of common stock.
- The transaction was executed to cover tax liabilities associated with the vesting of restricted stock units (RSUs).
- The shares were disposed of at a price of $2.58 per share.
- Following the transaction, Garcia directly owns 121,516 shares of ALX Oncology Holdings Inc.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock transactions for tax purposes, and does not indicate positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine disposal of shares for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 08/14/2024 | Date of the stock disposal transaction. |
| 08/16/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.